Innovative BioDefense Announces Partnership With Picketts Health to Sell Zylast
Innovative BioDefense Inc. (IBD), manufacturer of the Zylast line of broad-spectrum, persistent antimicrobial products, announces an exclusive relationship with Australian-based Picketts Health, to provide a modification of their proprietary lotion and antiseptic sanitizer for use in Picketts Health's patented Orbel hand sanitizer applicator. IBD has delivered a pilot production batch and is currently fulfilling Picketts' first orders. Picketts Health has committed to the purchase of $1.5 million in product from IBD during the first year, with a projection to increase to $4 million in the second year.
The Orbel was designed to increase hand-hygiene compliance and help prevent the spread of bacteria and viruses. Portable, with single-handed activation of a regulated dose, the Orbel's multi-directional balls evenly facilitate distribution to all parts of the hands for increased protection.
The Zylast line of antimicrobial products is all natural, water-based and triclosan-free. Zylast has shown to kill 99.99 percent of most disease-causing germs in 15 seconds and is persistent for six hours. Independent studies have shown Zylast to be effective against a broad spectrum of germs that includes 25 bacteria such as E. coli, S. pneumoniae, meningitis, methicillin-resistant S. aureus (MRSA) and vancomycin-resistant Enterococci (VRE), viruses such as rhinovirus, norovirus, H1N1, HIV and herpes, as well as molds and fungi.Â
"We are pleased Picketts Health has taken an important step toward solving the issue of compliance with the introduction of the Orbel," says Dr. Colette Cozean, chief executive officer for Innovative BioDefense Inc. "Their choice in bringing Zylast in as the formulary shows their commitment to providing the premier antimicrobial solution." The first markets Picketts Health plans to target are the United Kingdom, South Africa, Australia and China. Zylast is protected by trademarks and patents pending in many countries worldwide.
Source: Innovative BioDefense Inc.
The Guardians of Animal Health: Who Are Veterinary Infection Preventionists?
March 21st 2025Veterinary infection control experts Leslie Kollmann, BS, AAS, CVT, CIC, Denise Waiting, LVT, and Leslie Landis, LVT, BS, discuss challenges, zoonotic disease risks, and the importance of education, collaboration, and resource development in animal care facilities.
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Resilience and Innovation: The Pivotal Contributions of Black Americans to Health Care and Medicine
February 24th 2025During Black History Month, we honor the resilience and contributions of Black medical professionals in health care. Despite barriers, they have led transformative changes, advocating for equitable access and medical excellence. Recognizing their impact ensures a more inclusive health care future for all.
Glove Usage Guideline: From The Joint Commission, CDC, and World Health Organization
February 17th 2025Proper glove use is crucial in health care settings to prevent infections. Guidelines from TJC, CDC, and WHO stress correct selection, usage, and disposal to minimize health care–associated infections (HAIs) and cross-contamination risks. Infection preventionists (IPs) play a key role in educating staff, enforcing compliance, and improving patient safety through standardized glove practices.
